Molecular Imaging 2017

FDG-PET/CT in response assessment

CSS

PFS

the 2-year PFS rate was 96% for patients with CMR, and 28% for non- CMR patients (p<0.0001). The 2-year CSS rate was 100% for patients with CMR and 59% for non-CMR patients (p<0.0001).

Very high negative predictive value may prevent unnecessary biopsies or surgery